Lasiodiplodia keratitis: A case series of 27 patients

Smruti R Priyadarshini1, Alluri Himabindu1, Srikant K Sahu1

  • 1Cornea and Anterior Segment Service, L. V. Prasad Eye Institute, Bhubaneswar, Odisha, India.

PubMed
Abstract

Insights

This study found natamycin effective for Lasiodiplodia keratitis treatment. Advanced cases of fungal eye infections required surgery for full recovery, highlighting the need for prompt medical intervention.

Area of Science:

  • Ophthalmology
  • Medical Mycology
  • Infectious Diseases

Background:

  • Microbial keratitis is a significant cause of vision loss worldwide.
  • Lasiodiplodia theobromae is an emerging fungal pathogen causing ocular infections.
  • Understanding the clinical spectrum and management of Lasiodiplodia keratitis is crucial for effective treatment.

Purpose of the Study:

  • To review 27 cases of Lasiodiplodia theobromae-induced microbial keratitis.
  • To analyze risk factors, clinical presentation, and microbiological characteristics.
  • To evaluate treatment outcomes and identify predictors of success.

Main Methods:

  • Retrospective review of 27 microbial keratitis cases caused by Lasiodiplodia theobromae (Nov 2015 - Oct 2022).
  • Data collected from electronic medical records, including demographics, clinical findings, and treatment.
  • Descriptive statistics used to analyze patient data and treatment outcomes.

Main Results:

  • The average patient age was 56.8 years, with a male predominance (2.4:1).
  • Trauma history (40.7%) and large corneal infiltrates (>6 mm) were common presentations.
  • Topical natamycin-based medical treatment achieved successful outcomes in 66.7% of eyes; 33.3% required surgical intervention.

Conclusions:

  • Medical management, particularly with topical natamycin, is effective for Lasiodiplodia keratitis.
  • Advanced or severe cases may necessitate surgical intervention for complete resolution.
  • Early diagnosis and appropriate treatment are vital for managing fungal keratitis.